Reference #: 403400Site Name: UK - London - New Oxford Street, Baar Onyx, USA - Pennsylvania - Upper ProvidencePosted Date: Aug 27 2024

The VP, Global Medical Lead, IL-5 is a key senior business leadership role and member of the Global Medical Affairs, Specialty Medicines Leadership team.  This individual reports to the VP, Head of Global Medical Affairs, Specialty Medicines who is a key member of GSK's Chief Patient Officer Leadership Team.

The Global Medical Lead will have full responsibility for the Global Medical Strategy for both Mepolizumab and Depemokimab, both anti-IL5 monoclonal antibodies.  The Global Medical Lead will lead the translation of our science to shape the practice of medicine and deliver positive health impact for patients by providing healthcare decision-makers around the world with the evidence and confidence they need on GSK therapies, and influencing internal stakeholders with medical insight and expertise related to Development and Commercialization strategies. The role will be accountable for the medical strategic direction of an Asset or Portfolio of assets and the matrix leadership of the Global Asset Medical Leadership Team, integrating innovative strategies that advance patient care and help shape the practice of medicine.  The role will partner with key markets to ensure that their insights are used to inform all evidence, asset/vaccine development and strategic deliverables as well as partnering across Commercial and RD to deliver value for patients.

In addition to leading the Global Medical Team for Mepolizumab and Depemokimab, the incumbent will be a member of several additional matrix teams including the Medicines Development Team and the Medicine Commercial Team where he or she will provide Medical insight and expertise to inform and influence data generation and scientific communication plans across the lifecycle to optimize patient impact within markets.

A key focus of the role is to develop and stretch self and team to be the best in the industry at delivering impact for patients and improving patient care paradigms.

Key ResponsibilitiesLead the cross-functional global medical team and influence product development at the global levelAs chair of the global medical teamJointly accountable for developing the global medical brand strategy and plans for a product by convening the global medical teamSet direction along strategic framework of the medical brand plan including setting scientific objectives, own the medical scientific narrative and the integrated communication planAccountable for directing and coordinating global resources to generate data and create content to support priority markets, leveraging the expertise of the Global operations team and Global data teamRepresent medical in cross-functional strategy meetings and workshops, and proactively offer options for innovative medical strategy for the IAP at the MDT and MCT meetingsProvide focused support at key inflection points during development (e.g., launch)As Lead and Chair of the cross-functional global medical teamResponsible for representing the voice of the CPO organisation for a priority productAccountable for all medical activities related to product development at the global levelLead, coach, and mentor direct reports that support the global medical in development of medical brand strategy and plans, and execute and/or support execution of global tacticsAddress broader holistic disease area considerations as they arise by convening other relevant medical leads ad-hocPlay an active role within TA to articulate and implement a single, unified medical strategy across portfolio

Enterprise Leadership:Maximize the positive impact for patients and GSK from early development to maturity (defined as no further significant clinical evidence generation).Act as a partner to the MDL and MCL, ensure integrated and thoughtful insights from across a diverse stakeholder set contribu e to shaping the medicines vision, development strategy and clinical development in the early phases of development, and for refining medical strategy as clinical evidence is generated.Ensure that medical insights from the priority markets are incorporated into the GMT to inform all evidence, product development, and asset strategy deliverables.Accountable for leading the GMT in the development and delivery of the Global medical product strategy and associated global deliverables enabling prioritized LOCs to execute the strategy and deliver positive patient impact locally.Ensure that the evidence generation plan aligns to identified unmet needs and prioritized evidence gaps and addresses key medical and market access requirements, maximizing the asset competitiveness from launch through lifecycle management for priority marketsLead a global matrix team that executes on generation of evidence, publication plans and creation of content to support the priority markets to shape the practice of medicine and differentiate our medicines and vaccines.Act as medical Launch lead, partnering with cross-functional partners and priority markets to ensure timely and ambitious launchesSupport the cross-functional team, in partnership with the MDL and MCL for the development of ambitious LCI plansLead regular assessment of medical plan impact utilizing the medical impact framework, ensuring plan reviews and proactive communication of impact measures to key stakeholders as requiredOversee asset budget to ensure that resources are deployed against the highest the highest impact tacticsEnsure that Global deliverables are produced on time based on market needsUse a Global mindset, incorporating local perspectives, to strategy development and decision making. Partner with priority markets to understand their needs and balance options to achieve the set-out goals.

Performance culture:Maintains the patient at the center of everything we do.Full immersion in the science, disease area and business to be a true and equal partner to RD, Commercial and Key LOCs.Outstanding matrix leadership through the creation of a collaborative and cross-functional environment by fostering shared accountability and responsibility for delivery of specific goals and projects, and encouraging employees to work with diverse skill sets and learn from each other.Seek out, actively listen to and understand the needs of key markets and ensure they are appropriately reflected in the global strategy, inclusive of evidence generation and all other deliverables.Assess and understands the external environment, inclusive of the competitor landscape, to bring insights together to develop a clear, simple, compelling Medical strategy to improve outcomes for patientsAdopt a visionary and intuitive mindset, to anticipate current and future market value-drivers and evidence gaps and seek innovative solutions to them to support the long-term ambition for the asset/vaccine and its ultimate benefit for patientsQuickly adapt to unexpected external changes, understanding impact to strategy and ability to articulate implications for both RD and commercialIntegrate and synthesize deep understanding of the end-to-end asset development processes, inclusive of commercialization and interconnectivities to deliver practice change and impact for patients

People:Be a role model to all GSK employees, setting the right tone from the top while embedding a culture of performance underpinned by GSK Purpose, strategy and culture.Visibly leads with authenticity and confidence to gain followship for a workable plan, even in ambiguity.Creates cohesio